BIRC5 and osteosarcoma: The treatment upregulated cleaved caspase-3, cleaved caspase-9, phosphorylated H2Ax, Bax, Bak1, and cytochrome c, while downregulating survivin and Mcl-1 in osteosarcoma cells.